Like penicillins, cephalosporins, and carbapenems, monobactams also have a beta-lactam ring structure.

Mechanism of Action: Monobactams are bactericidal and work to inhibit bacterial cell wall synthesis.[1]

Indications: Monobactams are narrow-spectrum antibacterial medications that are used primarily to treat gram-negative bacteria such as Pseudomonas aeruginosa.

Nursing Considerations: Patients taking monobactams may experience adverse effects similar to other beta-lactam medications, so nurses should monitor for GI symptoms, skin sensitivities, and coagulation abnormalities.

Side Effects/Adverse Effects: Common side effects related to the use of monobactams includes nausea, vomiting, diarrhea, and abdominal pain. Additional adverse effects include skin rash and abnormal taste in the mouth.

Patient Teaching & Education: Patients should monitor for signs of superinfection and report any occurrence to the provider. If the patient experiences fever and bloody diarrhea, they should contact the provider immediately. The patient should also be advised to notify the provider immediately if symptoms progress or if any sign of allergic response occurs.[2]

Now let’s take a closer look at the medication grid for aztreonam in Table 3.8.[3] 

Table 3.8 Monobactam Medication Grid

Class/Subclass Prototype/Generic Administration Considerations Therapeutic Effects Side/Adverse Effects
Monobactams aztreonam Check for allergies to any beta lactams – penicillin, cephalosporins, or carbapenems

Can be administered IM, IV, or via inhalation

Monitor for systemic signs of infection:

-WBCs

-Fever

Monitor actual site of infection

Monitor culture results, if obtained

Similar to cephalosporins

Critical Thinking Activity 3.8Image of a circle containing a speech bubble with a question mark in it.

Using the above grid information, consider the following clinical scenario question:

A patient with cystic fibrosis is diagnosed with ventilator-associated pneumonia and is prescribed aztreonam (Azactam) 1 gm IV daily for a suspected Pseudomonas aeruginosa infection. The nurse reviews the culture results that just arrived and notices that the results indicate the infection is caused by Methicillin-resistant Staphylococcus aureus. Will this medication be effective against this bacterium? What is the nurse’s next best response?

Note: Answers to the Critical Thinking activities can be found in the “Answer Key” sections at the end of the book.

 


  1. This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https://openstax.org/books/microbiology/pages/1-introduction
  2. uCentral from Unbound Medicine. https://www.unboundmedicine.com/ucentral
  3. This work is a derivative of DailyMed by U.S. National Library of Medicine in the Public Domain.

License

Icon for the Creative Commons Attribution 4.0 International License

Nursing Pharmacology-2e UWEC Copyright © 2023 by Chippewa Valley Technical College is licensed under a Creative Commons Attribution 4.0 International License, except where otherwise noted.

Share This Book